Favorites Sign in
  1. Home
  2. Companies
  3. Stock RedHill Biopharma Ltd.
RedHill Biopharma Ltd. logo

RedHill Biopharma Ltd. RDHL

$ 0.48 0.2%
report update icon

Quarterly report 2025-Q2
added 05-27-2026

Country

 israelIsrael

IPO year

 -

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBAL

Shares

 12.3 B

Market Cap[1]

 $ 5.91 B

EBITDA (LTM)

 -

P/E (LTM)

 -

P/S (LTM)

 -

EPS (LTM)

 -

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Chiasma, Inc. Chiasma, Inc.
CHMA
 		- -6.00 % $ 238 M Nasdaq Global Select Market usaUSA
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
 		- - $ 376 M Nasdaq Global Market usaUSA
Cellect Biotechnology Ltd. Cellect Biotechnology Ltd.
APOP
 		- 0.38 % $ 12.9 M Nasdaq Global Select Market israelIsrael
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
AZRX
 		- 2.07 % $ 34.4 M Nasdaq Capital Market usaUSA
Cerecor Inc. Cerecor Inc.
CERC
 		- -1.68 % $ 283 M Nasdaq Capital Market usaUSA
Constellation Pharmaceuticals, Inc. Constellation Pharmaceuticals, Inc.
CNST
 		- - $ 1.63 B Nasdaq Global Select Market usaUSA
Auris Medical Holding Ltd. Auris Medical Holding Ltd.
EARS
 		- -1.77 % $ 39.2 M Nasdaq Capital Market bermudaBermuda
Dicerna Pharmaceuticals, Inc. Dicerna Pharmaceuticals, Inc.
DRNA
 		- 0.34 % $ 2.98 B Nasdaq Global Select Market,SPB usaUSA
ERYTECH Pharma S.A. ERYTECH Pharma S.A.
ERYP
 		- 1.3 % $ 27.7 M Nasdaq Global Select Market franceFrance
GW Pharmaceuticals plc GW Pharmaceuticals plc
GWPH
 		- - $ 6.81 B Nasdaq Global Select Market britainBritain
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
 		- - $ 1.7 B Nasdaq Global Select Market usaUSA
Liminal BioSciences Liminal BioSciences
LMNL
 		- - $ 256 M Nasdaq Global Market canadaCanada
Neos Therapeutics, Inc. Neos Therapeutics, Inc.
NEOS
 		- -2.54 % $ 57.2 M Nasdaq Global Market usaUSA
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.
ODT
 		- -3.18 % $ 58.5 M Nasdaq Global Select Market usaUSA
Orphazyme A/S Orphazyme A/S
ORPH
 		- -2.25 % $ 31.3 M Nasdaq Global Select Market danmarkDanmark
Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc
OSMT
 		- -10.74 % $ 89.9 M Nasdaq Global Select Market usaUSA
Pandion Therapeutics, Inc. Pandion Therapeutics, Inc.
PAND
 		- - $ 1.77 B Nasdaq Global Select Market usaUSA
Translate Bio, Inc. Translate Bio, Inc.
TBIO
 		- - $ 2.81 B Nasdaq Global Select Market,SPB usaUSA
Trillium Therapeutics Inc. Trillium Therapeutics Inc.
TRIL
 		- - $ 1.94 B Nasdaq Capital Market canadaCanada
Urovant Sciences Ltd. Urovant Sciences Ltd.
UROV
 		- - $ 532 M Nasdaq Global Select Market britainBritain
Acceleron Pharma Inc. Acceleron Pharma Inc.
XLRN
 		- - $ 10.9 B Nasdaq Global Market,SPB usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
 		- 0.52 % $ 821 M Nasdaq Global Select Market danmarkDanmark
Zogenix, Inc. Zogenix, Inc.
ZGNX
 		- -4.97 % $ 664 M Nasdaq Global Market,SPB usaUSA
Yunhong International Yunhong International
ZGYH
 		- 0.10 % $ 92.2 M Nasdaq Capital Market chinaChina
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
ZIOP
 		- -7.58 % $ 264 M Nasdaq Global Select Market usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
 		- 368.57 % $ 41.9 M Nasdaq Global Market usaUSA
Cortexyme Cortexyme
CRTX
 		- -1.05 % $ 67.1 M Nasdaq Global Select Market,SPB usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
 		- - $ 5.72 M Nasdaq Global Select Market chinaChina
FSD Pharma FSD Pharma
HUGE
 		- 5743.5 % $ 69.7 M Nasdaq Capital Market canadaCanada
BioAtla BioAtla
BCAB
 		$ 1.74 0.64 % $ 102 M Nasdaq Global Select Market usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
 		- - $ 3.85 B Nasdaq Capital Market usaUSA
ARCA biopharma ARCA biopharma
ABIO
 		- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Acasti Pharma Acasti Pharma
ACST
 		- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
ADiTx Therapeutics ADiTx Therapeutics
ADTX
 		- - $ 374 Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
 		- -10.17 % $ 12.2 K NYSE American usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		- - $ 1.01 B Nasdaq Global Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
 		- 10.36 % $ 9.8 M Nasdaq Global Select Market usaUSA
AlloVir AlloVir
ALVR
 		- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
 		- - $ 5.18 B Nasdaq Global Select Market,SPB usaUSA
Athira Pharma Athira Pharma
ATHA
 		- - $ 269 M Nasdaq Global Select Market usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
 		- -52.27 % $ 4.45 M Nasdaq Global Select Market usaUSA
AVROBIO AVROBIO
AVRO
 		- 1083.1 % $ 745 M Nasdaq Global Select Market usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
 		- - $ 96.9 B Nasdaq Global Select Market britainBritain
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
 		- -2.5 % $ 5.88 M Nasdaq Capital Market usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Bio-Path Holdings Bio-Path Holdings
BPTH
 		- - $ 100 K Nasdaq Capital Market usaUSA
Cara Therapeutics Cara Therapeutics
CARA
 		- -3.03 % $ 260 M Nasdaq Global Market,SPB usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
 		- -0.88 % $ 598 M Nasdaq Capital Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.